MedPath

MYLAN PHARMACEUTICALS INC.

🇺🇸United States
Ownership
-
Employees
-
Market Cap
-
Website

Fasting Study of Olanzapine Tablets 5 mg and Zyprexa® Tablets 5 mg

Phase 1
Completed
Conditions
Healthy
Interventions
First Posted Date
2008-04-01
Last Posted Date
2024-04-24
Lead Sponsor
Mylan Pharmaceuticals Inc
Target Recruit Count
30
Registration Number
NCT00648921
Locations
🇺🇸

Kendle International Inc., Morgantown, West Virginia, United States

Fed Study of Alprazolam Extended-release Tablets 3 mg to Xanax XR® Tablets 3 mg

First Posted Date
2008-04-01
Last Posted Date
2024-04-24
Lead Sponsor
Mylan Pharmaceuticals Inc
Target Recruit Count
21
Registration Number
NCT00650299
Locations
🇺🇸

Kendle International Inc., Morgantown, West Virginia, United States

Fed Study of Albuterol Sulfate Extended-Release Tablets 8 mg and VoSpire® ER Tablets 8 mg

Phase 1
Completed
Conditions
Healthy
Interventions
First Posted Date
2008-04-01
Last Posted Date
2024-04-24
Lead Sponsor
Mylan Pharmaceuticals Inc
Target Recruit Count
21
Registration Number
NCT00649987
Locations
🇺🇸

PRACS Institute, Ltd., Fargo, North Dakota, United States

Fed Study of Zonisamide Capsules 100 mg and Zonegran® Capsules 100 mg

Phase 1
Completed
Conditions
Healthy
Interventions
First Posted Date
2008-04-01
Last Posted Date
2024-04-23
Lead Sponsor
Mylan Pharmaceuticals Inc
Target Recruit Count
110
Registration Number
NCT00649714
Locations
🇺🇸

Kendle International Inc., Morgantown, West Virginia, United States

Food Study of Nitrofurantoin Monohydrate/Macrocrystals Capsules 100 mg and Macrobid® Capsules 100 mg

First Posted Date
2008-04-01
Last Posted Date
2024-04-24
Lead Sponsor
Mylan Pharmaceuticals Inc
Target Recruit Count
71
Registration Number
NCT00649285
Locations
🇺🇸

Kendle International Inc., Morgantown, West Virginia, United States

Fasting Study of Doxycycline Monohydrate Tablets 150 mg and Adoxa Tablets 150 mg

Phase 1
Completed
Conditions
Healthy
Interventions
First Posted Date
2008-04-01
Last Posted Date
2024-04-24
Lead Sponsor
Mylan Pharmaceuticals Inc
Target Recruit Count
36
Registration Number
NCT00647959
Locations
🇺🇸

Kendle International Inc., Morgantown, West Virginia, United States

Fasting Study of Modafinil Tablets 200 mg and Provigil® Tablets 200 mg

Phase 1
Completed
Conditions
Healthy
Interventions
First Posted Date
2008-04-01
Last Posted Date
2024-04-24
Lead Sponsor
Mylan Pharmaceuticals Inc
Target Recruit Count
32
Registration Number
NCT00650000
Locations
🇺🇸

Kendle International Inc., Morgantown, West Virginia, United States

Steady-State Study of Extended Phenytoin Sodium Capsules 100 mg and Dilantin® Kapseals® 100 mg

Phase 1
Completed
Conditions
Healthy
Interventions
Drug: Extended Phenytoin Sodium Capsules 100 mg
First Posted Date
2008-04-01
Last Posted Date
2024-04-24
Lead Sponsor
Mylan Pharmaceuticals Inc
Target Recruit Count
72
Registration Number
NCT00647621
Locations
🇺🇸

PRACS Institute, Ltd., Fargo, North Dakota, United States

Food Study of Metoprolol Tartrate/Hydrochlorothiazide Tablets 100/50 mg to Lopressor HCT® Tablets 100/50 mg

First Posted Date
2008-04-01
Last Posted Date
2024-04-24
Lead Sponsor
Mylan Pharmaceuticals Inc
Target Recruit Count
32
Registration Number
NCT00649233
Locations
🇺🇸

PRACS Institute, Ltd., Fargo, North Dakota, United States

Fasting Study of Pioglitazone HCl Tablets 45 mg and Actos® Tablets 45 mg

Phase 1
Completed
Conditions
Healthy
Interventions
First Posted Date
2008-04-01
Last Posted Date
2024-04-24
Lead Sponsor
Mylan Pharmaceuticals Inc
Target Recruit Count
36
Registration Number
NCT00649558
Locations
🇺🇸

PRACS Institute, Ltd., Fargo, North Dakota, United States

© Copyright 2025. All Rights Reserved by MedPath